| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastroesophageal Reflux | 19 | 2015 | 338 | 3.090 |
Why?
|
| Esomeprazole | 9 | 2015 | 33 | 2.510 |
Why?
|
| Endoscopy, Gastrointestinal | 14 | 2012 | 240 | 2.250 |
Why?
|
| Proton Pump Inhibitors | 7 | 2015 | 282 | 1.760 |
Why?
|
| Endoscopy, Digestive System | 9 | 2018 | 157 | 1.690 |
Why?
|
| Esophagitis, Peptic | 7 | 2015 | 37 | 1.400 |
Why?
|
| Gastrointestinal Diseases | 9 | 2014 | 356 | 1.350 |
Why?
|
| Abdominal Pain | 10 | 2014 | 314 | 1.330 |
Why?
|
| Conscious Sedation | 8 | 2011 | 60 | 1.240 |
Why?
|
| Child, Preschool | 55 | 2018 | 14736 | 0.860 |
Why?
|
| Esophagoscopy | 9 | 2010 | 168 | 0.830 |
Why?
|
| Intestinal Mucosa | 5 | 2018 | 797 | 0.800 |
Why?
|
| Sucrase-Isomaltase Complex | 2 | 2012 | 19 | 0.780 |
Why?
|
| Starch | 2 | 2012 | 26 | 0.780 |
Why?
|
| Norwalk virus | 10 | 2015 | 170 | 0.780 |
Why?
|
| Gastrointestinal Hemorrhage | 6 | 2012 | 237 | 0.770 |
Why?
|
| Digestion | 2 | 2012 | 44 | 0.770 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 2 | 2012 | 39 | 0.760 |
Why?
|
| Anti-Ulcer Agents | 5 | 2015 | 115 | 0.760 |
Why?
|
| Dietary Carbohydrates | 2 | 2012 | 108 | 0.740 |
Why?
|
| Child | 65 | 2018 | 25784 | 0.680 |
Why?
|
| Infant | 39 | 2015 | 13049 | 0.670 |
Why?
|
| Peptic Ulcer | 4 | 2015 | 150 | 0.610 |
Why?
|
| Adolescent | 47 | 2018 | 20561 | 0.590 |
Why?
|
| Disaccharidases | 1 | 2018 | 15 | 0.580 |
Why?
|
| Esophagitis | 3 | 2008 | 38 | 0.570 |
Why?
|
| Malabsorption Syndromes | 1 | 2018 | 29 | 0.570 |
Why?
|
| Pediatrics | 8 | 2015 | 1210 | 0.560 |
Why?
|
| Wound Healing | 4 | 2015 | 475 | 0.550 |
Why?
|
| Duodenum | 1 | 2018 | 113 | 0.540 |
Why?
|
| Dyspepsia | 1 | 2018 | 108 | 0.530 |
Why?
|
| Midazolam | 3 | 2011 | 44 | 0.510 |
Why?
|
| Colonoscopy | 5 | 2015 | 250 | 0.510 |
Why?
|
| Esophagus | 5 | 2011 | 234 | 0.500 |
Why?
|
| Double-Blind Method | 9 | 2015 | 1653 | 0.480 |
Why?
|
| Helicobacter Infections | 9 | 2018 | 1278 | 0.470 |
Why?
|
| Helicobacter pylori | 9 | 2018 | 1336 | 0.460 |
Why?
|
| Caliciviridae Infections | 7 | 2015 | 361 | 0.460 |
Why?
|
| Humans | 96 | 2018 | 132256 | 0.440 |
Why?
|
| Ketamine | 2 | 2011 | 226 | 0.440 |
Why?
|
| Colonic Polyps | 2 | 2012 | 83 | 0.430 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2009 | 326 | 0.410 |
Why?
|
| Male | 55 | 2018 | 65018 | 0.410 |
Why?
|
| Intestine, Large | 1 | 2012 | 14 | 0.390 |
Why?
|
| Platelet Activating Factor | 1 | 2012 | 23 | 0.390 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2012 | 28 | 0.390 |
Why?
|
| Adenomatous Polyps | 1 | 2012 | 13 | 0.390 |
Why?
|
| Gastroenteritis | 6 | 2015 | 365 | 0.380 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2012 | 53 | 0.380 |
Why?
|
| Female | 53 | 2018 | 70791 | 0.380 |
Why?
|
| Intestinal Perforation | 2 | 2012 | 56 | 0.370 |
Why?
|
| Constipation | 3 | 2013 | 128 | 0.340 |
Why?
|
| Glucocorticoids | 2 | 2012 | 387 | 0.340 |
Why?
|
| Antibodies, Viral | 7 | 2015 | 1204 | 0.330 |
Why?
|
| Immunoglobulin G | 6 | 2015 | 803 | 0.330 |
Why?
|
| Infant, Premature, Diseases | 1 | 2012 | 252 | 0.330 |
Why?
|
| Gastroenterology | 5 | 2014 | 211 | 0.330 |
Why?
|
| Cross-Sectional Studies | 12 | 2011 | 3761 | 0.320 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2012 | 248 | 0.310 |
Why?
|
| Gastroscopy | 4 | 2008 | 102 | 0.300 |
Why?
|
| Magnets | 3 | 2014 | 23 | 0.300 |
Why?
|
| Barrett Esophagus | 2 | 2011 | 355 | 0.300 |
Why?
|
| Hernia, Hiatal | 2 | 2008 | 60 | 0.300 |
Why?
|
| Fundoplication | 4 | 2014 | 70 | 0.300 |
Why?
|
| Databases as Topic | 2 | 2007 | 76 | 0.290 |
Why?
|
| Hypnotics and Sedatives | 2 | 2004 | 137 | 0.290 |
Why?
|
| Colonoscopes | 1 | 2008 | 10 | 0.290 |
Why?
|
| Cardia | 1 | 2008 | 26 | 0.280 |
Why?
|
| Esophageal Achalasia | 2 | 2014 | 46 | 0.280 |
Why?
|
| Colonic Diseases | 1 | 2008 | 38 | 0.280 |
Why?
|
| Opportunistic Infections | 1 | 2007 | 80 | 0.260 |
Why?
|
| Colorectal Neoplasms | 1 | 2012 | 630 | 0.250 |
Why?
|
| Prevalence | 10 | 2012 | 2664 | 0.250 |
Why?
|
| Enema | 3 | 1995 | 44 | 0.240 |
Why?
|
| Infant, Newborn | 12 | 2015 | 8548 | 0.240 |
Why?
|
| Treatment Outcome | 13 | 2015 | 13030 | 0.240 |
Why?
|
| Prospective Studies | 10 | 2018 | 6569 | 0.240 |
Why?
|
| Autistic Disorder | 1 | 2009 | 387 | 0.240 |
Why?
|
| Risk Factors | 16 | 2014 | 10946 | 0.230 |
Why?
|
| Cytomegalovirus Infections | 1 | 2007 | 224 | 0.230 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 589 | 0.230 |
Why?
|
| Diarrhea | 4 | 2015 | 331 | 0.220 |
Why?
|
| Gastric Mucosa | 1 | 2008 | 491 | 0.220 |
Why?
|
| Biopsy | 6 | 2011 | 1288 | 0.220 |
Why?
|
| Therapeutic Irrigation | 2 | 1995 | 45 | 0.220 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2007 | 214 | 0.220 |
Why?
|
| Age Factors | 10 | 2014 | 2923 | 0.210 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 6 | 2011 | 826 | 0.210 |
Why?
|
| Retrospective Studies | 14 | 2018 | 17396 | 0.210 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2003 | 13 | 0.200 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 1996 | 236 | 0.200 |
Why?
|
| Esophageal Diseases | 3 | 1997 | 37 | 0.190 |
Why?
|
| Caustics | 1 | 2001 | 5 | 0.180 |
Why?
|
| Colitis, Ulcerative | 2 | 2015 | 217 | 0.180 |
Why?
|
| Foreign Bodies | 2 | 2013 | 110 | 0.180 |
Why?
|
| Headache | 2 | 2015 | 110 | 0.180 |
Why?
|
| Esophageal Stenosis | 1 | 2001 | 46 | 0.180 |
Why?
|
| Feces | 7 | 2015 | 753 | 0.180 |
Why?
|
| Incidence | 5 | 2013 | 3377 | 0.170 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2000 | 38 | 0.170 |
Why?
|
| Confidence Intervals | 3 | 2011 | 277 | 0.160 |
Why?
|
| Biopsy, Needle | 1 | 2000 | 234 | 0.160 |
Why?
|
| Meperidine | 2 | 2004 | 8 | 0.160 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2000 | 73 | 0.160 |
Why?
|
| Societies, Medical | 5 | 2014 | 779 | 0.150 |
Why?
|
| Oxygen | 2 | 2011 | 569 | 0.150 |
Why?
|
| Colitis | 2 | 2000 | 165 | 0.150 |
Why?
|
| Immunoglobulin A | 4 | 2015 | 218 | 0.140 |
Why?
|
| Rotavirus Infections | 4 | 1998 | 359 | 0.140 |
Why?
|
| Logistic Models | 5 | 2014 | 1841 | 0.140 |
Why?
|
| Manometry | 1 | 1997 | 72 | 0.130 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2018 | 132 | 0.130 |
Why?
|
| Crohn Disease | 1 | 2000 | 291 | 0.130 |
Why?
|
| Pyloric Stenosis | 1 | 1996 | 10 | 0.130 |
Why?
|
| United States | 9 | 2018 | 11675 | 0.130 |
Why?
|
| Chi-Square Distribution | 2 | 2008 | 588 | 0.130 |
Why?
|
| Mycobacterium avium Complex | 1 | 1996 | 20 | 0.130 |
Why?
|
| Liver Diseases | 1 | 2000 | 385 | 0.130 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 1996 | 24 | 0.130 |
Why?
|
| Liver | 2 | 2000 | 1797 | 0.120 |
Why?
|
| Virus Shedding | 3 | 2013 | 82 | 0.120 |
Why?
|
| Barium Sulfate | 1 | 1995 | 14 | 0.120 |
Why?
|
| Deglutition | 2 | 2013 | 60 | 0.120 |
Why?
|
| Catheterization | 1 | 1996 | 241 | 0.120 |
Why?
|
| Ileal Diseases | 1 | 1995 | 28 | 0.110 |
Why?
|
| Biological Therapy | 1 | 2015 | 25 | 0.110 |
Why?
|
| Surveys and Questionnaires | 4 | 2011 | 3995 | 0.110 |
Why?
|
| Sensitivity and Specificity | 3 | 2008 | 2139 | 0.110 |
Why?
|
| Chronic Disease | 3 | 2010 | 1233 | 0.110 |
Why?
|
| Documentation | 1 | 2015 | 121 | 0.110 |
Why?
|
| Cross Reactions | 1 | 2014 | 189 | 0.110 |
Why?
|
| Intestinal Polyps | 2 | 2011 | 29 | 0.110 |
Why?
|
| Breath Tests | 4 | 2009 | 182 | 0.110 |
Why?
|
| Fecal Impaction | 1 | 1994 | 9 | 0.110 |
Why?
|
| Intestinal Obstruction | 1 | 1995 | 96 | 0.110 |
Why?
|
| Serotonin 5-HT4 Receptor Agonists | 1 | 2013 | 1 | 0.100 |
Why?
|
| Adrenal Insufficiency | 1 | 2014 | 31 | 0.100 |
Why?
|
| Laxatives | 1 | 2013 | 9 | 0.100 |
Why?
|
| Household Articles | 1 | 2013 | 3 | 0.100 |
Why?
|
| Cathartics | 1 | 1993 | 31 | 0.100 |
Why?
|
| Reproducibility of Results | 5 | 2010 | 3018 | 0.100 |
Why?
|
| Gastrointestinal Agents | 1 | 2014 | 64 | 0.100 |
Why?
|
| Defecation | 1 | 2013 | 34 | 0.100 |
Why?
|
| Child Welfare | 1 | 2014 | 64 | 0.100 |
Why?
|
| Play and Playthings | 1 | 2013 | 18 | 0.100 |
Why?
|
| Benzofurans | 1 | 2013 | 24 | 0.100 |
Why?
|
| Diazepam | 1 | 1993 | 21 | 0.100 |
Why?
|
| Antibody Formation | 2 | 2012 | 274 | 0.100 |
Why?
|
| Intestines | 2 | 2012 | 606 | 0.100 |
Why?
|
| Quality Indicators, Health Care | 1 | 2015 | 236 | 0.100 |
Why?
|
| Anesthesia | 1 | 1995 | 216 | 0.100 |
Why?
|
| Celecoxib | 1 | 2012 | 32 | 0.100 |
Why?
|
| Age of Onset | 2 | 2012 | 626 | 0.100 |
Why?
|
| History, 20th Century | 2 | 2007 | 385 | 0.100 |
Why?
|
| Pentoxifylline | 1 | 2012 | 20 | 0.100 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2012 | 48 | 0.100 |
Why?
|
| Colon | 1 | 2015 | 370 | 0.090 |
Why?
|
| Hemagglutination, Viral | 1 | 2011 | 10 | 0.090 |
Why?
|
| Hepatitis, Viral, Human | 1 | 1992 | 45 | 0.090 |
Why?
|
| Intussusception | 1 | 2012 | 55 | 0.090 |
Why?
|
| Nutritional Status | 1 | 2014 | 294 | 0.090 |
Why?
|
| Arab World | 1 | 2011 | 1 | 0.090 |
Why?
|
| Rectal Diseases | 1 | 2011 | 21 | 0.090 |
Why?
|
| DiGeorge Syndrome | 1 | 1992 | 82 | 0.090 |
Why?
|
| Recurrence | 4 | 2010 | 1453 | 0.090 |
Why?
|
| Adult | 17 | 2015 | 31620 | 0.090 |
Why?
|
| Peptide Hydrolases | 1 | 2012 | 143 | 0.090 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 1992 | 106 | 0.090 |
Why?
|
| Fluoroimmunoassay | 1 | 2011 | 6 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 305 | 0.090 |
Why?
|
| Time Factors | 5 | 2014 | 6452 | 0.090 |
Why?
|
| Gastrointestinal Tract | 1 | 2013 | 232 | 0.090 |
Why?
|
| Antibodies, Neutralizing | 1 | 2014 | 500 | 0.090 |
Why?
|
| Antigens, Viral | 1 | 2012 | 439 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2007 | 1966 | 0.080 |
Why?
|
| Sulfonamides | 1 | 2012 | 284 | 0.080 |
Why?
|
| Antibodies, Blocking | 1 | 2010 | 63 | 0.080 |
Why?
|
| Pyrazoles | 1 | 2012 | 330 | 0.080 |
Why?
|
| Microbiota | 1 | 2015 | 434 | 0.080 |
Why?
|
| Young Adult | 7 | 2015 | 9970 | 0.080 |
Why?
|
| Cell Membrane Permeability | 1 | 2009 | 72 | 0.080 |
Why?
|
| Pancreatitis | 1 | 2010 | 140 | 0.080 |
Why?
|
| Trachea | 1 | 2011 | 210 | 0.080 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1993 | 479 | 0.080 |
Why?
|
| Minnesota | 1 | 2009 | 180 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 3 | 2012 | 1304 | 0.070 |
Why?
|
| Intestinal Absorption | 1 | 2009 | 176 | 0.070 |
Why?
|
| Illinois | 1 | 2008 | 17 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 2010 | 235 | 0.070 |
Why?
|
| Registries | 1 | 2015 | 1591 | 0.070 |
Why?
|
| Sickness Impact Profile | 1 | 2008 | 39 | 0.070 |
Why?
|
| Saliva | 2 | 2015 | 133 | 0.070 |
Why?
|
| Eosinophils | 1 | 2009 | 122 | 0.070 |
Why?
|
| Severity of Illness Index | 4 | 2014 | 3093 | 0.070 |
Why?
|
| Sex Factors | 2 | 2009 | 1354 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2014 | 1036 | 0.070 |
Why?
|
| Kidney Diseases | 1 | 1992 | 490 | 0.070 |
Why?
|
| Thyrotoxicosis | 1 | 2007 | 6 | 0.070 |
Why?
|
| Postoperative Complications | 3 | 2014 | 3139 | 0.070 |
Why?
|
| Endoscopes, Gastrointestinal | 2 | 2004 | 8 | 0.070 |
Why?
|
| Contraceptives, Oral | 1 | 2007 | 41 | 0.070 |
Why?
|
| North America | 2 | 2005 | 265 | 0.070 |
Why?
|
| Multicenter Studies as Topic | 1 | 2008 | 312 | 0.070 |
Why?
|
| Intestine, Small | 1 | 2009 | 309 | 0.070 |
Why?
|
| Vomiting | 2 | 1999 | 108 | 0.070 |
Why?
|
| Infant, Premature | 1 | 2012 | 843 | 0.070 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2009 | 234 | 0.060 |
Why?
|
| Thyroidectomy | 1 | 2007 | 102 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2008 | 1444 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 2442 | 0.060 |
Why?
|
| Research | 3 | 2004 | 266 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 2 | 2007 | 576 | 0.060 |
Why?
|
| Developmental Disabilities | 1 | 2011 | 749 | 0.060 |
Why?
|
| History, 21st Century | 1 | 2007 | 271 | 0.060 |
Why?
|
| Colonography, Computed Tomographic | 2 | 2004 | 15 | 0.060 |
Why?
|
| Algorithms | 1 | 2012 | 1725 | 0.060 |
Why?
|
| Hypoxia | 1 | 2007 | 259 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2007 | 3414 | 0.060 |
Why?
|
| Monitoring, Physiologic | 2 | 2000 | 377 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 1671 | 0.050 |
Why?
|
| Benchmarking | 1 | 2005 | 138 | 0.050 |
Why?
|
| Comorbidity | 1 | 2009 | 1610 | 0.050 |
Why?
|
| Life Style | 1 | 2007 | 453 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2011 | 5412 | 0.050 |
Why?
|
| Endoscopy | 2 | 2004 | 288 | 0.050 |
Why?
|
| Antibodies, Bacterial | 2 | 2002 | 406 | 0.050 |
Why?
|
| Asthma | 1 | 2010 | 773 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2010 | 926 | 0.050 |
Why?
|
| Gastritis | 2 | 2003 | 372 | 0.050 |
Why?
|
| Gastroplasty | 1 | 2001 | 12 | 0.050 |
Why?
|
| Administration, Oral | 4 | 2013 | 699 | 0.040 |
Why?
|
| Burns, Chemical | 1 | 2001 | 29 | 0.040 |
Why?
|
| Respiratory Tract Diseases | 1 | 2001 | 80 | 0.040 |
Why?
|
| Prognosis | 1 | 2011 | 5016 | 0.040 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2001 | 81 | 0.040 |
Why?
|
| Equipment Safety | 1 | 2000 | 37 | 0.040 |
Why?
|
| Blood Coagulation Tests | 1 | 2000 | 62 | 0.040 |
Why?
|
| Needles | 1 | 2000 | 53 | 0.040 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2000 | 47 | 0.040 |
Why?
|
| Megacolon | 1 | 2000 | 4 | 0.040 |
Why?
|
| Hematocrit | 1 | 2000 | 111 | 0.040 |
Why?
|
| Aspartate Aminotransferases | 1 | 2000 | 84 | 0.040 |
Why?
|
| Alkaline Phosphatase | 1 | 2000 | 97 | 0.040 |
Why?
|
| Hirschsprung Disease | 1 | 2000 | 38 | 0.040 |
Why?
|
| Diet | 1 | 2007 | 1125 | 0.040 |
Why?
|
| Peritonitis | 1 | 2000 | 76 | 0.040 |
Why?
|
| Alanine Transaminase | 1 | 2000 | 162 | 0.040 |
Why?
|
| Benzodiazepines | 1 | 2000 | 108 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2003 | 571 | 0.040 |
Why?
|
| Hemoglobins | 1 | 2000 | 322 | 0.040 |
Why?
|
| Sialic Acids | 1 | 1999 | 19 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2000 | 334 | 0.040 |
Why?
|
| Lactose | 1 | 1999 | 55 | 0.040 |
Why?
|
| Hospitals, Pediatric | 2 | 2014 | 780 | 0.040 |
Why?
|
| Fasting | 1 | 2000 | 302 | 0.040 |
Why?
|
| Virion | 1 | 1999 | 151 | 0.040 |
Why?
|
| Viral Vaccines | 2 | 2000 | 343 | 0.040 |
Why?
|
| Lactoferrin | 1 | 1999 | 73 | 0.040 |
Why?
|
| Rotavirus | 2 | 1992 | 505 | 0.040 |
Why?
|
| Serologic Tests | 2 | 2011 | 130 | 0.030 |
Why?
|
| Child Nutritional Physiological Phenomena | 3 | 2004 | 156 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2000 | 1177 | 0.030 |
Why?
|
| Gastric Outlet Obstruction | 1 | 1996 | 15 | 0.030 |
Why?
|
| Adjuvants, Immunologic | 1 | 1999 | 392 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2000 | 518 | 0.030 |
Why?
|
| Hypertrophy | 1 | 1996 | 101 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2014 | 1255 | 0.030 |
Why?
|
| Methylprednisolone | 1 | 1996 | 98 | 0.030 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1996 | 70 | 0.030 |
Why?
|
| Prednisone | 1 | 1996 | 253 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2000 | 988 | 0.030 |
Why?
|
| Treatment Failure | 1 | 1996 | 364 | 0.030 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2015 | 55 | 0.030 |
Why?
|
| Obesity | 1 | 2007 | 2398 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2000 | 471 | 0.030 |
Why?
|
| Blastocystis hominis | 1 | 1994 | 1 | 0.030 |
Why?
|
| Anesthesia, General | 1 | 1995 | 124 | 0.030 |
Why?
|
| Blastocystis Infections | 1 | 1994 | 5 | 0.030 |
Why?
|
| Transfusion Reaction | 1 | 2014 | 39 | 0.030 |
Why?
|
| Urea | 2 | 2009 | 231 | 0.030 |
Why?
|
| Solutions | 1 | 1993 | 59 | 0.030 |
Why?
|
| Bicarbonates | 1 | 1994 | 100 | 0.030 |
Why?
|
| Infliximab | 1 | 2014 | 69 | 0.030 |
Why?
|
| Chlorides | 1 | 1994 | 103 | 0.030 |
Why?
|
| Virus Replication | 2 | 1999 | 636 | 0.030 |
Why?
|
| Health Transition | 1 | 2013 | 11 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1993 | 258 | 0.030 |
Why?
|
| Tablets | 1 | 2013 | 35 | 0.030 |
Why?
|
| Consumer Product Safety | 1 | 2013 | 31 | 0.030 |
Why?
|
| Granuloma | 1 | 1994 | 66 | 0.030 |
Why?
|
| Colectomy | 1 | 2014 | 84 | 0.030 |
Why?
|
| Sutures | 1 | 1994 | 69 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2015 | 356 | 0.030 |
Why?
|
| Placebos | 1 | 2013 | 235 | 0.030 |
Why?
|
| Acute Disease | 2 | 2010 | 1163 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2015 | 650 | 0.030 |
Why?
|
| Gastrointestinal Motility | 1 | 2013 | 55 | 0.020 |
Why?
|
| Fecal Incontinence | 1 | 2013 | 78 | 0.020 |
Why?
|
| Potassium | 1 | 1994 | 275 | 0.020 |
Why?
|
| Neodymium | 1 | 2012 | 6 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2013 | 321 | 0.020 |
Why?
|
| Human Experimentation | 1 | 2012 | 35 | 0.020 |
Why?
|
| Sodium | 1 | 1994 | 296 | 0.020 |
Why?
|
| Patients | 1 | 1993 | 129 | 0.020 |
Why?
|
| Diarrhea, Infantile | 1 | 1992 | 35 | 0.020 |
Why?
|
| Immunoassay | 1 | 2012 | 135 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 1992 | 249 | 0.020 |
Why?
|
| Oximetry | 1 | 1993 | 178 | 0.020 |
Why?
|
| Seroepidemiologic Studies | 2 | 2003 | 144 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2000 | 1103 | 0.020 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2011 | 114 | 0.020 |
Why?
|
| Radiography | 1 | 2014 | 819 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 956 | 0.020 |
Why?
|
| Adolescent Behavior | 1 | 2013 | 171 | 0.020 |
Why?
|
| Child Behavior | 1 | 2013 | 236 | 0.020 |
Why?
|
| Aging | 1 | 1998 | 1254 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2014 | 5176 | 0.020 |
Why?
|
| Socioeconomic Factors | 2 | 2007 | 902 | 0.020 |
Why?
|
| Pain | 1 | 1994 | 462 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2013 | 416 | 0.020 |
Why?
|
| Middle Aged | 5 | 2013 | 29026 | 0.020 |
Why?
|
| Texas | 2 | 2014 | 3632 | 0.020 |
Why?
|
| Eating | 1 | 2012 | 381 | 0.020 |
Why?
|
| Biological Assay | 1 | 2010 | 111 | 0.020 |
Why?
|
| Polysaccharides | 1 | 2010 | 148 | 0.020 |
Why?
|
| Cerebral Palsy | 1 | 2010 | 85 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 2009 | 56 | 0.020 |
Why?
|
| CD8 Antigens | 1 | 2009 | 45 | 0.020 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2009 | 56 | 0.020 |
Why?
|
| Carbon Isotopes | 1 | 2009 | 233 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 2703 | 0.020 |
Why?
|
| Rabbits | 3 | 1998 | 673 | 0.020 |
Why?
|
| Laparoscopy | 1 | 2014 | 523 | 0.020 |
Why?
|
| Overweight | 1 | 2010 | 383 | 0.020 |
Why?
|
| Electrocardiography | 1 | 1993 | 996 | 0.020 |
Why?
|
| DNA Primers | 1 | 2008 | 636 | 0.020 |
Why?
|
| Reference Values | 1 | 2009 | 703 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2008 | 239 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2009 | 436 | 0.020 |
Why?
|
| Urease | 1 | 2006 | 74 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 387 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2008 | 565 | 0.020 |
Why?
|
| Education | 1 | 2006 | 111 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2009 | 449 | 0.020 |
Why?
|
| Metaplasia | 1 | 2006 | 217 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2013 | 1171 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2006 | 1008 | 0.010 |
Why?
|
| Factor Analysis, Statistical | 1 | 2005 | 236 | 0.010 |
Why?
|
| Base Sequence | 1 | 2008 | 2900 | 0.010 |
Why?
|
| Endosonography | 1 | 2004 | 82 | 0.010 |
Why?
|
| Probability | 1 | 2004 | 322 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2004 | 448 | 0.010 |
Why?
|
| Intellectual Disability | 1 | 2010 | 1094 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2003 | 327 | 0.010 |
Why?
|
| Age Distribution | 1 | 2003 | 437 | 0.010 |
Why?
|
| Research Design | 1 | 2006 | 743 | 0.010 |
Why?
|
| Inflammation | 1 | 2009 | 1522 | 0.010 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2002 | 87 | 0.010 |
Why?
|
| Psychometrics | 1 | 2005 | 693 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2006 | 930 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2007 | 1700 | 0.010 |
Why?
|
| Immunity, Mucosal | 1 | 2000 | 94 | 0.010 |
Why?
|
| Colostrum | 1 | 1999 | 58 | 0.010 |
Why?
|
| Vaccines, Synthetic | 1 | 2000 | 322 | 0.010 |
Why?
|
| Precancerous Conditions | 1 | 2002 | 280 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 2313 | 0.010 |
Why?
|
| Antibodies | 1 | 1999 | 366 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1999 | 441 | 0.010 |
Why?
|
| Disease Progression | 1 | 2004 | 2233 | 0.010 |
Why?
|
| Cattle | 1 | 1999 | 569 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1998 | 293 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2002 | 1234 | 0.010 |
Why?
|
| Animals | 5 | 1999 | 34850 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1996 | 247 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1999 | 1350 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2004 | 3736 | 0.010 |
Why?
|
| Gastric Fundus | 1 | 1994 | 9 | 0.010 |
Why?
|
| Metronidazole | 1 | 1994 | 156 | 0.010 |
Why?
|
| Rectum | 1 | 1994 | 114 | 0.010 |
Why?
|
| Polyps | 1 | 1994 | 43 | 0.010 |
Why?
|
| Viral Plaque Assay | 1 | 1991 | 42 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 1991 | 237 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1991 | 216 | 0.010 |
Why?
|
| Kinetics | 1 | 1991 | 1130 | 0.000 |
Why?
|
| Mice | 1 | 1998 | 18507 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1991 | 4690 | 0.000 |
Why?
|
| Aged | 1 | 1999 | 21483 | 0.000 |
Why?
|